PRINCIPALI PUBBLICAZIONI SCIENTIFICHE su QMR e REXON EYE:

​

Riferimenti bibliografici citati in merito alla QMR, altri studi su www.teleamedical.com:

• “In-vitro analysis of Quantum Molecular Resonance effects on human mesenchymal stromal cells”, Sella S, Adami V, Amati E, Bernardi M, Chieregato K, Gatto P, et al. PLoS ONE (2018)

• “Biophysical effects of high frequency electrical field (4-64 MHz) on muscle fibers in culture”, Dal Maschio M, Canato M, Pigozzo FM, Basic Applied Myology (2009); 19:49–56.

• “NLRP3 Inflammasome inhibition and promoting M1 to M2 macrophage polarization by quantum molecular resonance: potential therapeutic effect in osteoarthritis”, Paolucci, T.; Pino, V.; Elsallabi, O.; Gallorini, M.; Pozzato, G.; Pozzato, A.; Lanuti, P.; Reis, V.M.; Pesce, M.; Pantalone, A.; et al. Antioxidants (2023),12,1358 

• “Quantum molecular resonance technology in hard-to-heal extremity wounds: histological and clinical results”. M. Fraccalvieri, M. Salomone, C. Di Santo, E. Ruka U. Morozzo, S. Bruschi S. Int Wound J 2017; 14:1313–1322.

Principali riferimenti bibliografici sul REXON EYE per i trattamento dell’occhio secco, altri studi su www.resono.it:

• Pedrotti E, Bosello F, Fasolo A, Frigo AC, Marchesoni I, Ruggeri A, Marchini G. Transcutaneous periorbital electrical stimulation in the treatment of dry eye. Br J Ophthalmol 2017; 101:814–9.

• Ferrari G, Colucci A, Barbariga M, Ruggeri A, Rama P. High frequency electrotherapy for the treatment of Meibomian Gland Dysfunction. Cornea 2019; 38 (11):1424-9.

• Ruggeri A, Fatigati E, Vigo L. Mixed dry eye patients successfully treated by the innovative high-frequency electrotherapy device Rexon-Eye®. Invest. Ophthalmol. Vis. Sci. 2020; 61(7):114.

• Trivli A, Karmiris E, Dalianis G, Ruggeri A, Terzidou C. Evaluating the efficacy of Quantum Molecular Resonance (QMR) electrotherapy in mixed-type dry eye patients. J Optom. 2022 Jul 15:S1888-4296(22)00037-1. doi: 10.1016/j.optom.2022.06.003. Epub ahead of print. PMID: 35851496.

• Kopalova K, Ruggeri A, High - frequency QMR electric field in the treatment of dry eye disease, EuDEC Symposium, Paris, Jul 10-11, 2022.

• Shemer A, Nusbaum L, Altarescu A, Vardi M, Dubinsky-Pertzov B, Hecht I, Pras E, Einan-Lifshitz A, Quantum Molecular Resonance Effects On Patients With Dry Eye Disease: A Randomised-Controlled Trail, Proc ESCRS 2022 Congress, Milan, Sep 16-20, 2022.

• Uthaithammarat L, Reinprayoon U, Chongpison Y, Kasetsuwan N, Efficacy of quantum molecular resonance in treating meibomian gland dysfunction, Proc. ACS 2022 Congress, Bangkok, Nov 23-25, 2022.

• Kavroulaki D, Konstantinidou E, Tsiogka A, Rallis K, Mavrikakis E. Quantum Molecular Resonance Electrical Stimulation as a Beneficial and Safe Treatment for Multifactorial Dry Eye Disease. Cureus. 2023 May 30;15(5):e39695. doi: 10.7759/cureus.39695

• Foo VHX, Liu YC, Tho B, Tong L. Quantum molecular resonance electrotherapy (Rexon-Eye) for recalcitrant dry eye in an Asian population. Front Med (Lausanne). 2023 Sep 12;10:1209886. doi: 10.3389/fmed.2023.1209886

• Ballesteros-Sánchez A, Sánchez-González JM, Tedesco GR, Rocha-De-Lossada C, Russo F, Spinelli A, Ingrande I, Borroni D. Efficacy and Safety of Quantum Molecular Resonance Electrotherapy in Patients with Aqueous-Deficient, Evaporative and Mixed-Type Dry Eye: A Randomized Interventional Study. Ophthalmol Ther. 2023 Dec 19. doi: 10.1007/s40123-023-00868-w. Epub ahead of print. PMID: 38113022.